Laparoscopic nephrectomy for renal cell cancer: Evaluation of efficacy and safety: A multicenter experience

Jeffrey A Cadeddu, Yoshinari Ono, Ralph V. Clayman, Peter H. Barrett, Gunter Janetschek, Donald D. Fentie, Elspeth M. McDougall, Robert G. Moore, Tsuneo Kinukawa, Abdelhamid M. Elbahnasy, Joel B. Nelson, Louis R. Kavoussi

Research output: Contribution to journalArticle

215 Citations (Scopus)

Abstract

Objectives. Although laparoscopic radical nephrectomy is a safe and minimally invasive alternative to open surgery, the long-term disease-free outcome of this procedure has not been reported. We evaluated our experience with the laparoscopic management of renal cell carcinoma to assess the clinical efficacy of this surgical modality. Methods. Between February 1991 and June 1997, 157 patients at five institutions were retrospectively identified who had clinically localized, pathologically confirmed, renal cell carcinoma and had undergone laparoscopic radical nephrectomy. Operative and clinical records were reviewed to determine morbidity, disease-free status, and cancer-specific survival. Of the patients followed up for at least 12 months (n = 101), 75% had an abdominal computed tomography scan at their last visit. Results. The mean age at surgery was 61 years (range 27 to 92) and all patients were clinical Stage T1-2,N0,M0. Fifteen patients (9.6%) had perioperative complications. During a mean follow-up of 19.2 months (range 1 to 72; 51 patients with 2 years or more of follow-up), no patient developed a laparoscopic port site or renal fossa tumor recurrence. Four patients developed metastatic disease, and 1 patient developed a local recurrence. The 5-year actuarial disease-free rate was 91% ± 4.8 (SE). At last follow-up, there were no cancer-specific mortalities. Conclusions. The laparoscopic surgical management of localized renal cell carcinoma is feasible. Short- term results indicate that laparoscopic radical nephrectomy is not associated with an increased risk of port site or retroperitoneal recurrence. Longer follow-up is necessary to compare long-term survival and disease-free rates with those of open surgery.

Original languageEnglish (US)
Pages (from-to)773-777
Number of pages5
JournalUrology
Volume52
Issue number5
DOIs
StatePublished - Nov 1998

Fingerprint

Nephrectomy
Renal Cell Carcinoma
Safety
Recurrence
Neoplasms
Disease-Free Survival
Tomography
Morbidity
Kidney
Survival
Mortality

ASJC Scopus subject areas

  • Urology

Cite this

Cadeddu, J. A., Ono, Y., Clayman, R. V., Barrett, P. H., Janetschek, G., Fentie, D. D., ... Kavoussi, L. R. (1998). Laparoscopic nephrectomy for renal cell cancer: Evaluation of efficacy and safety: A multicenter experience. Urology, 52(5), 773-777. https://doi.org/10.1016/S0090-4295(98)00391-4

Laparoscopic nephrectomy for renal cell cancer : Evaluation of efficacy and safety: A multicenter experience. / Cadeddu, Jeffrey A; Ono, Yoshinari; Clayman, Ralph V.; Barrett, Peter H.; Janetschek, Gunter; Fentie, Donald D.; McDougall, Elspeth M.; Moore, Robert G.; Kinukawa, Tsuneo; Elbahnasy, Abdelhamid M.; Nelson, Joel B.; Kavoussi, Louis R.

In: Urology, Vol. 52, No. 5, 11.1998, p. 773-777.

Research output: Contribution to journalArticle

Cadeddu, JA, Ono, Y, Clayman, RV, Barrett, PH, Janetschek, G, Fentie, DD, McDougall, EM, Moore, RG, Kinukawa, T, Elbahnasy, AM, Nelson, JB & Kavoussi, LR 1998, 'Laparoscopic nephrectomy for renal cell cancer: Evaluation of efficacy and safety: A multicenter experience', Urology, vol. 52, no. 5, pp. 773-777. https://doi.org/10.1016/S0090-4295(98)00391-4
Cadeddu, Jeffrey A ; Ono, Yoshinari ; Clayman, Ralph V. ; Barrett, Peter H. ; Janetschek, Gunter ; Fentie, Donald D. ; McDougall, Elspeth M. ; Moore, Robert G. ; Kinukawa, Tsuneo ; Elbahnasy, Abdelhamid M. ; Nelson, Joel B. ; Kavoussi, Louis R. / Laparoscopic nephrectomy for renal cell cancer : Evaluation of efficacy and safety: A multicenter experience. In: Urology. 1998 ; Vol. 52, No. 5. pp. 773-777.
@article{93bd32e3083843e5a2744f6da29effb7,
title = "Laparoscopic nephrectomy for renal cell cancer: Evaluation of efficacy and safety: A multicenter experience",
abstract = "Objectives. Although laparoscopic radical nephrectomy is a safe and minimally invasive alternative to open surgery, the long-term disease-free outcome of this procedure has not been reported. We evaluated our experience with the laparoscopic management of renal cell carcinoma to assess the clinical efficacy of this surgical modality. Methods. Between February 1991 and June 1997, 157 patients at five institutions were retrospectively identified who had clinically localized, pathologically confirmed, renal cell carcinoma and had undergone laparoscopic radical nephrectomy. Operative and clinical records were reviewed to determine morbidity, disease-free status, and cancer-specific survival. Of the patients followed up for at least 12 months (n = 101), 75{\%} had an abdominal computed tomography scan at their last visit. Results. The mean age at surgery was 61 years (range 27 to 92) and all patients were clinical Stage T1-2,N0,M0. Fifteen patients (9.6{\%}) had perioperative complications. During a mean follow-up of 19.2 months (range 1 to 72; 51 patients with 2 years or more of follow-up), no patient developed a laparoscopic port site or renal fossa tumor recurrence. Four patients developed metastatic disease, and 1 patient developed a local recurrence. The 5-year actuarial disease-free rate was 91{\%} ± 4.8 (SE). At last follow-up, there were no cancer-specific mortalities. Conclusions. The laparoscopic surgical management of localized renal cell carcinoma is feasible. Short- term results indicate that laparoscopic radical nephrectomy is not associated with an increased risk of port site or retroperitoneal recurrence. Longer follow-up is necessary to compare long-term survival and disease-free rates with those of open surgery.",
author = "Cadeddu, {Jeffrey A} and Yoshinari Ono and Clayman, {Ralph V.} and Barrett, {Peter H.} and Gunter Janetschek and Fentie, {Donald D.} and McDougall, {Elspeth M.} and Moore, {Robert G.} and Tsuneo Kinukawa and Elbahnasy, {Abdelhamid M.} and Nelson, {Joel B.} and Kavoussi, {Louis R.}",
year = "1998",
month = "11",
doi = "10.1016/S0090-4295(98)00391-4",
language = "English (US)",
volume = "52",
pages = "773--777",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Laparoscopic nephrectomy for renal cell cancer

T2 - Evaluation of efficacy and safety: A multicenter experience

AU - Cadeddu, Jeffrey A

AU - Ono, Yoshinari

AU - Clayman, Ralph V.

AU - Barrett, Peter H.

AU - Janetschek, Gunter

AU - Fentie, Donald D.

AU - McDougall, Elspeth M.

AU - Moore, Robert G.

AU - Kinukawa, Tsuneo

AU - Elbahnasy, Abdelhamid M.

AU - Nelson, Joel B.

AU - Kavoussi, Louis R.

PY - 1998/11

Y1 - 1998/11

N2 - Objectives. Although laparoscopic radical nephrectomy is a safe and minimally invasive alternative to open surgery, the long-term disease-free outcome of this procedure has not been reported. We evaluated our experience with the laparoscopic management of renal cell carcinoma to assess the clinical efficacy of this surgical modality. Methods. Between February 1991 and June 1997, 157 patients at five institutions were retrospectively identified who had clinically localized, pathologically confirmed, renal cell carcinoma and had undergone laparoscopic radical nephrectomy. Operative and clinical records were reviewed to determine morbidity, disease-free status, and cancer-specific survival. Of the patients followed up for at least 12 months (n = 101), 75% had an abdominal computed tomography scan at their last visit. Results. The mean age at surgery was 61 years (range 27 to 92) and all patients were clinical Stage T1-2,N0,M0. Fifteen patients (9.6%) had perioperative complications. During a mean follow-up of 19.2 months (range 1 to 72; 51 patients with 2 years or more of follow-up), no patient developed a laparoscopic port site or renal fossa tumor recurrence. Four patients developed metastatic disease, and 1 patient developed a local recurrence. The 5-year actuarial disease-free rate was 91% ± 4.8 (SE). At last follow-up, there were no cancer-specific mortalities. Conclusions. The laparoscopic surgical management of localized renal cell carcinoma is feasible. Short- term results indicate that laparoscopic radical nephrectomy is not associated with an increased risk of port site or retroperitoneal recurrence. Longer follow-up is necessary to compare long-term survival and disease-free rates with those of open surgery.

AB - Objectives. Although laparoscopic radical nephrectomy is a safe and minimally invasive alternative to open surgery, the long-term disease-free outcome of this procedure has not been reported. We evaluated our experience with the laparoscopic management of renal cell carcinoma to assess the clinical efficacy of this surgical modality. Methods. Between February 1991 and June 1997, 157 patients at five institutions were retrospectively identified who had clinically localized, pathologically confirmed, renal cell carcinoma and had undergone laparoscopic radical nephrectomy. Operative and clinical records were reviewed to determine morbidity, disease-free status, and cancer-specific survival. Of the patients followed up for at least 12 months (n = 101), 75% had an abdominal computed tomography scan at their last visit. Results. The mean age at surgery was 61 years (range 27 to 92) and all patients were clinical Stage T1-2,N0,M0. Fifteen patients (9.6%) had perioperative complications. During a mean follow-up of 19.2 months (range 1 to 72; 51 patients with 2 years or more of follow-up), no patient developed a laparoscopic port site or renal fossa tumor recurrence. Four patients developed metastatic disease, and 1 patient developed a local recurrence. The 5-year actuarial disease-free rate was 91% ± 4.8 (SE). At last follow-up, there were no cancer-specific mortalities. Conclusions. The laparoscopic surgical management of localized renal cell carcinoma is feasible. Short- term results indicate that laparoscopic radical nephrectomy is not associated with an increased risk of port site or retroperitoneal recurrence. Longer follow-up is necessary to compare long-term survival and disease-free rates with those of open surgery.

UR - http://www.scopus.com/inward/record.url?scp=0031771927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031771927&partnerID=8YFLogxK

U2 - 10.1016/S0090-4295(98)00391-4

DO - 10.1016/S0090-4295(98)00391-4

M3 - Article

C2 - 9801097

AN - SCOPUS:0031771927

VL - 52

SP - 773

EP - 777

JO - Urology

JF - Urology

SN - 0090-4295

IS - 5

ER -